Ginkgo Bioworks Holdings Price to Book Ratio 2020-2023 | DNA

Historical price to book ratio values for Ginkgo Bioworks Holdings (DNA) over the last 10 years. The current price to book ratio for Ginkgo Bioworks Holdings as of May 26, 2023 is 1.97.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Ginkgo Bioworks Holdings Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2023-05-26 1.52 1.71
2023-03-31 1.33 $0.89 1.50
2022-12-31 1.69 $1.03 1.65
2022-09-30 3.12 $0.87 3.57
2022-06-30 2.38 $0.96 2.48
2022-03-31 4.03 $1.00 4.05
2021-12-31 8.31 $0.97 8.54
2021-09-30 11.59 $1.09 10.65
2021-06-30 9.96 $0.07 137.57
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $3.170B $0.478B
Ginkgo Bioworks platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks, formerly known as Soaring Eagle Acquisition Corp., is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $134.076B 8.19
GSK (GSK) United Kingdom $70.106B 9.78
Bio-Rad Laboratories (BIO.B) United States $11.071B 29.60
QIAGEN (QGEN) Netherlands $10.491B 22.15
Arcus Biosciences (RCUS) United States $1.611B 0.00
Biohaven (BHVN) United States $1.059B 0.00
Emergent Biosolutions (EBS) United States $0.412B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.175B 0.00
Enzo Biochem (ENZ) United States $0.114B 0.00
SQZ Biotechnologies (SQZ) United States $0.017B 0.00